Ofir Moreno

A veteran biotech executive, with a passion for integrating advanced techniques and technologies toward the discovery and development of new drugs. Demonstrated success discovering novel small molecule drugs and targeted drug conjugates utilizing a variety of technological platforms and the application of model-informed drugs. He held leading roles at MEI Pharma, Znomics, Dendreon, Amgen, and Merck.